Stock Radar: Biocon stock hits fresh 52-week high in November 2025; check target & stop loss

Biocon stock has crossed a significant resistance level. Experts recommend buying the stock for potential gains in the coming weeks. The pharma stock showed a strong bounce back in November, rising over 10% in a week. This momentum helped it break out from a multi-year resistance mark. The Supertrend indicator signals continued upside momentum.